Koninklijke Philips N.V.

ENXTAM:PHIA Stock Report

Market Cap: €17.2b

Koninklijke Philips Past Earnings Performance

Past criteria checks 0/6

Koninklijke Philips's earnings have been declining at an average annual rate of -56%, while the Medical Equipment industry saw earnings growing at 5.8% annually. Revenues have been declining at an average rate of 0.7% per year.

Key information

-56.0%

Earnings growth rate

-55.9%

EPS growth rate

Medical Equipment Industry Growth12.3%
Revenue growth rate-0.7%
Return on equity-3.8%
Net Margin-2.5%
Next Earnings Update29 Apr 2024

Recent past performance updates

Recent updates

Here's Why Koninklijke Philips (AMS:PHIA) Has A Meaningful Debt Burden

Mar 21
Here's Why Koninklijke Philips (AMS:PHIA) Has A Meaningful Debt Burden

Lacklustre Performance Is Driving Koninklijke Philips N.V.'s (AMS:PHIA) Low P/S

Jan 21
Lacklustre Performance Is Driving Koninklijke Philips N.V.'s (AMS:PHIA) Low P/S

Does Koninklijke Philips (AMS:PHIA) Have A Healthy Balance Sheet?

Dec 16
Does Koninklijke Philips (AMS:PHIA) Have A Healthy Balance Sheet?

Koninklijke Philips (AMS:PHIA) Is Making Moderate Use Of Debt

Sep 17
Koninklijke Philips (AMS:PHIA) Is Making Moderate Use Of Debt

Is There Now An Opportunity In Koninklijke Philips N.V. (AMS:PHIA)?

Jul 16
Is There Now An Opportunity In Koninklijke Philips N.V. (AMS:PHIA)?

Is There An Opportunity With Koninklijke Philips N.V.'s (AMS:PHIA) 47% Undervaluation?

Jun 12
Is There An Opportunity With Koninklijke Philips N.V.'s (AMS:PHIA) 47% Undervaluation?

Health Check: How Prudently Does Koninklijke Philips (AMS:PHIA) Use Debt?

Mar 30
Health Check: How Prudently Does Koninklijke Philips (AMS:PHIA) Use Debt?

Revenue & Expenses Breakdown
Beta

How Koninklijke Philips makes and spends money. Based on latest reported earnings, on an LTM basis.


Earnings and Revenue History

ENXTAM:PHIA Revenue, expenses and earnings (EUR Millions)
DateRevenueEarningsG+A ExpensesR&D Expenses
31 Dec 2318,169-4565,1531,890
30 Sep 2318,529-6095,2451,820
30 Jun 2318,368-2,0355,3141,986
31 Mar 2318,076-2,1325,3082,002
31 Dec 2217,827-1,6215,3021,957
30 Sep 2217,349-1,3634,9721,974
30 Jun 2217,1944024,8541,790
31 Mar 2217,2474914,7851,776
31 Dec 2117,1566084,8651,806
30 Sep 2119,6691,1735,2501,757
30 Jun 2117,7038114,6271,630
31 Mar 2119,6691,1475,0981,741
31 Dec 2017,3139914,5641,691
30 Sep 2019,4921,1425,0941,724
30 Jun 2018,3279664,8571,660
31 Mar 2019,4901,0555,2121,691
31 Dec 1917,1479844,5821,639
30 Sep 1919,1101,3545,2191,761
30 Jun 1918,7141,4525,0861,707
31 Mar 1918,3301,3815,1041,701
31 Dec 1818,1211,3035,0031,683
30 Sep 1817,8381,0224,9441,640
30 Jun 1817,6808714,9151,676
31 Mar 1817,6878084,8321,672
31 Dec 1717,7808144,8311,660
30 Sep 1717,7838304,7541,731
30 Jun 1717,7928764,7201,708
31 Mar 1724,7241,1056,5942,037
31 Dec 1617,4227884,6231,648
30 Sep 1619,2112185,4351,741
30 Jun 1620,8902485,9201,784
31 Mar 1622,7323656,4041,855
31 Dec 1516,8061455,1211,562
30 Sep 1523,6855906,4701,820
30 Jun 1523,0432286,2751,721
31 Mar 1522,0381916,0011,638
31 Dec 1421,3912255,9301,635
28 Sep 1420,3734375,7121,498
29 Jun 1420,7748395,7421,575
30 Mar 1421,4379745,8341,601
31 Dec 1321,9901,0315,9031,657
29 Sep 1323,2313096,0191,746
30 Jun 1323,4571326,0731,744

Quality Earnings: PHIA is currently unprofitable.

Growing Profit Margin: PHIA is currently unprofitable.


Free Cash Flow vs Earnings Analysis


Past Earnings Growth Analysis

Earnings Trend: PHIA is unprofitable, and losses have increased over the past 5 years at a rate of 56% per year.

Accelerating Growth: Unable to compare PHIA's earnings growth over the past year to its 5-year average as it is currently unprofitable

Earnings vs Industry: PHIA is unprofitable, making it difficult to compare its past year earnings growth to the Medical Equipment industry (2.4%).


Return on Equity

High ROE: PHIA has a negative Return on Equity (-3.76%), as it is currently unprofitable.


Return on Assets


Return on Capital Employed


Discover strong past performing companies

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.